Colgate-Palmolive's 15min chart triggers Bollinger Bands expansion, KDJ golden cross.
ByAinvest
Tuesday, Aug 5, 2025 10:34 am ET1min read
BINI--
Colgate-Palmolive is a global leader in consumer products, specializing in oral care, personal care, home care, and pet nutrition. The company's strong brand portfolio includes Colgate toothpaste and Palmolive dish soap, competing with major consumer goods companies like Procter & Gamble and Unilever [1].
Key executives, including John Faucher and Noel R. Wallace, discussed the company's financial performance and strategic initiatives during the earnings call. Pricing strategies contributed a 2% increase to organic growth, counterbalancing flat volume and foreign exchange-related sales pressures [1]. However, higher raw-material and packaging costs, including those tied to tariffs, are expected to weigh on margins, with an estimated $75 million in tariff-related costs this year [2].
Colgate plans to raise prices and adjust product sizes to hit the low end of its full-year organic sales outlook. The company expects about $200 million to $300 million in related charges in the next three years as part of a broader productivity initiative aimed at simplifying its organizational structure and optimizing its supply chain [2].
Analysts polled by FactSet expect full-year sales of $20.33 billion, a 1.1% increase from last year, and statutory per-share earnings of $3.66, roughly flat on the last 12 months [3]. The consensus price target remains at $98.17, reflecting the analysts' view that the business is executing well in line with expectations.
Looking ahead, Colgate's 15-minute chart indicates bullish sentiment, with Bollinger Bands expanding upward and the KDJ indicator triggering a golden cross on August 5, 2025, at 10:30. This suggests potential for further price increases [4].
References:
[1] https://site.financialmodelingprep.com/market-news/colgate-palmolive-q2-2025-earnings-adjusts-sales-growth-forecast
[2] https://www.tradingview.com/news/DJN_DN20250801008392:0-colgate-plans-more-price-increases-to-offset-slower-sales-higher-costs-update/
[3] https://simplywall.st/stocks/us/household/nyse-cl/colgate-palmolive/news/colgate-palmolive-company-nysecl-second-quarter-results-just
[4] Based on the provided writing topic.
CL--
FDS--
PG--
UL--
Based on Colgate-Palmolive's 15-minute chart, the Bollinger Bands are expanding upward, and the KDJ indicator has triggered a golden cross at 08/05/2025 at 10:30. This indicates that the market trend is being driven by bullish sentiment, and the momentum of the stock price is shifting towards the upside. As a result, there is potential for further price increases.
Colgate-Palmolive Company (NYSE:CL) reported its second-quarter (Q2) 2025 earnings on August 1, 2025, with earnings per share (EPS) of $0.92 and net sales of $5.11 billion. The company adjusted its full-year organic sales growth forecast to the lower end of its 2-4% guidance range [1]. Despite strong earnings, Colgate's stock experienced a slight decrease of approximately -0.47%, trading at $83.12 [1].Colgate-Palmolive is a global leader in consumer products, specializing in oral care, personal care, home care, and pet nutrition. The company's strong brand portfolio includes Colgate toothpaste and Palmolive dish soap, competing with major consumer goods companies like Procter & Gamble and Unilever [1].
Key executives, including John Faucher and Noel R. Wallace, discussed the company's financial performance and strategic initiatives during the earnings call. Pricing strategies contributed a 2% increase to organic growth, counterbalancing flat volume and foreign exchange-related sales pressures [1]. However, higher raw-material and packaging costs, including those tied to tariffs, are expected to weigh on margins, with an estimated $75 million in tariff-related costs this year [2].
Colgate plans to raise prices and adjust product sizes to hit the low end of its full-year organic sales outlook. The company expects about $200 million to $300 million in related charges in the next three years as part of a broader productivity initiative aimed at simplifying its organizational structure and optimizing its supply chain [2].
Analysts polled by FactSet expect full-year sales of $20.33 billion, a 1.1% increase from last year, and statutory per-share earnings of $3.66, roughly flat on the last 12 months [3]. The consensus price target remains at $98.17, reflecting the analysts' view that the business is executing well in line with expectations.
Looking ahead, Colgate's 15-minute chart indicates bullish sentiment, with Bollinger Bands expanding upward and the KDJ indicator triggering a golden cross on August 5, 2025, at 10:30. This suggests potential for further price increases [4].
References:
[1] https://site.financialmodelingprep.com/market-news/colgate-palmolive-q2-2025-earnings-adjusts-sales-growth-forecast
[2] https://www.tradingview.com/news/DJN_DN20250801008392:0-colgate-plans-more-price-increases-to-offset-slower-sales-higher-costs-update/
[3] https://simplywall.st/stocks/us/household/nyse-cl/colgate-palmolive/news/colgate-palmolive-company-nysecl-second-quarter-results-just
[4] Based on the provided writing topic.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet